[email protected] +91 9789129171
ICCPATH · Registering as Listener

International Conference on Cancer Pathology

28 - 29 Apr 2027 Quetta, Pakistan Standard / Physical Participation
Listener Registration
$120
virtual · $135 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICCPATH
ModeStandard / Physical
ParticipationListener
Registration fee$135.00
Bank charges (5.8%)$7.83
Total payable$142.83
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

ICCPATH conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure
01 Advancements in Cancer Diagnostics +
This track will explore the latest innovations in cancer diagnostic techniques, focusing on the integration of histopathology and molecular oncology. Emphasis will be placed on the role of advanced imaging and biomarker discovery in enhancing diagnostic accuracy.
02 Tumor Markers: Clinical Applications and Challenges +
This session will examine the clinical utility of tumor markers in cancer diagnosis and monitoring. Discussions will include the challenges associated with the specificity and sensitivity of these biomarkers in various cancer types.
03 Immunohistochemistry in Cancer Pathology +
This track will delve into the applications of immunohistochemistry in the characterization of tumors. Participants will discuss the latest techniques and their implications for personalized medicine.
04 Molecular Oncology: Pathways and Targets +
This session will focus on the molecular mechanisms underlying cancer pathogenesis and the identification of novel therapeutic targets. Researchers will present findings on signaling pathways and their relevance to tumor biology.
05 Translational Research in Cancer Pathology +
This track will highlight the importance of translational research in bridging laboratory findings with clinical applications. Presentations will cover recent breakthroughs that have the potential to impact patient care.
06 Histopathological Techniques and Innovations +
This session will showcase cutting-edge histopathological techniques that enhance the understanding of cancer morphology. Participants will discuss the implications of these innovations for diagnostic pathology.
07 Clinical Trials: Emerging Therapies in Oncology +
This track will focus on the design and outcomes of recent clinical trials evaluating novel cancer therapies. Discussions will include the role of pathology in trial design and patient stratification.
08 Biomarker Discovery: Challenges and Opportunities +
This session will explore the current landscape of biomarker discovery in cancer research. Participants will discuss the methodologies employed and the potential for biomarkers to revolutionize cancer treatment.
09 Disease Mechanisms in Cancer Progression +
This track will investigate the underlying mechanisms that drive cancer progression and metastasis. Researchers will present their findings on genetic, epigenetic, and environmental factors influencing disease outcomes.
10 Integrative Approaches in Cancer Pathology +
This session will emphasize the importance of integrative approaches combining histopathology, genomics, and proteomics in understanding cancer. Discussions will focus on how these multidisciplinary strategies can enhance diagnostic and therapeutic outcomes.
11 Future Directions in Cancer Pathology Research +
This track will provide a platform for discussing future research directions in cancer pathology. Participants will explore emerging trends, technologies, and collaborative efforts aimed at advancing the field.